BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260223
DTEND;VALUE=DATE:20260227
DTSTAMP:20260515T010942
CREATED:20251021T104830Z
LAST-MODIFIED:20251021T104830Z
UID:42225-1771804800-1772150399@www.pharmajournalist.com
SUMMARY:16th World ADC London
DESCRIPTION:The Longest Standing & Pre-Eminent European ADC Forum\n16th World ADC London | 800+ Industry Attendees | 240+ Companies | 110+ Global Speakers \nWith traditional ADCs now fulfilling their potential to reshape oncology care\, the bioconjugate community is doubling down on differentiation to ensure the next generation delivers meaningful patient impact. \nReturning as the longest-standing and definitive ADC forum in Europe\, 16th World ADC London 2026 is the must-attend event for anyone working in or looking to learn about bioconjugates. Leverage cutting-edge R&D\, strategic insights\, and unparalleled networking to advance ADC innovation and maximise therapeutic potential. \nAgenda Highlights:\nThe 2026 programme features 5 end-to-end content streams covering discovery\, preclinical translation\, clinical lessons\, process & analytical development\, and manufacturing & supply chain. Sessions are infused with trailblazing approaches to overcome patient resistance and accelerate ADCs into earlier-line oncology treatments. Topics include: \n\nNovel cytotoxic and non-cytotoxic payloads\nDual payload ADCs\nBispecific and biparatopic ADCs\nNon-antibody and fragment conjugates\n\nGlobal Speaker Faculty:\nHear from 110+ experts across Europe\, North America\, and Asia sharing actionable insights to advance your pipeline\, including: \n\nElaine Hurt\, Executive Director & Head\, Tumour Targeted Delivery Bioscience\, Oncology R&D\, AstraZeneca\nGuillaume Bergthold\, Executive Director\, Clinical Development\, Daiichi Sankyo\nAlan Russell\, VP Research & Head\, R&D Technology & Innovation\, Amgen\nAndras Strassz\, Chief Medical Officer\, Heidelberg Pharma\nMarija Vrljic\, VP\, Antibody Technologies\, ALX Oncology (New Company)\nJonathan Davis\, Director\, ADC Discovery\, Helix Biopharma (New Company)\nZhenwei Miao\, Founder & Chairman\, Adcoris Biopharma (New Company)\n\nWho Will Attend:\nJoin 800+ senior ADC decision-makers from biopharma\, clinical research\, service providers\, investors\, and regulators\, uniting to shape the future of ADC development. \nExplore the full agenda for a complete breakdown of all sessions\, speakers\, and networking opportunities.
URL:http://www.pharmajournalist.com/event/16th-world-adc-london/
LOCATION:ExCeL London\, Royal Victoria Dock\, 1 Western Gateway\, London\, E16 1XL\, United Kingdom
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260223
DTEND;VALUE=DATE:20260225
DTSTAMP:20260515T010942
CREATED:20260106T121653Z
LAST-MODIFIED:20260106T121736Z
UID:42640-1771804800-1771977599@www.pharmajournalist.com
SUMMARY:SmartLab Exchange Europe
DESCRIPTION:Across pharma\, biotech\, chemicals\, FMCG\, and beyond\, laboratory leaders are facing the same challenge: how to turn the vision of a smart\, digital lab into reality. From harmonising data and making it AI-ready to unlocking the true value of automation\, the journey from concept to execution is complex – but critical. \nSmartLab Exchange Europe 2026 is where innovation meets implementation. This exclusive\, invitation-only event brings together senior laboratory\, R&D\, and digital transformation leaders to focus on practical strategies that make digitalisation work in practice. Over two days in Amsterdam\, you’ll explore how to overcome data silos\, scale automation\, and drive adoption – from the bench to the boardroom. \nThrough curated roundtables\, one-to-one meetings\, and real-world case studies\, you’ll gain actionable insights on: \n\nHow to efficiently sort your lab data so that it becomes ‘FAIR’\nPractical steps to make sure data is AI-ready\nCase studies from those already implementing AI and Automation to prove the value that can be unlocked\nHow to overcome resistance and drive change across teams and systems\n\nWho Should Attend?\nSenior professionals in R&D\, QA/QC\, IT\, and digital transformation roles from pharma\, biotech\, chemicals\, FMCG\, and food & beverage organisations. \nLearn More:\nView the event guide to explore the full agenda\, speaker lineup\, and venue details to see why the SmartLab Exchange Europe is the must-attend event for laboratory leaders. \nSpaces are strictly limited. Secure your invitation today and join us in Amsterdam for two days of strategic collaboration and innovation.
URL:http://www.pharmajournalist.com/event/smartlab-exchange-europe-2026/
LOCATION:Leonardo Royal Hotel Amsterdam\, Netherlands
ORGANIZER;CN="IQPC Exchange":MAILTO:enquire@iqpc.co.uk
END:VEVENT
END:VCALENDAR